Sergei Gryaznov - Apr 30, 2024 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Chief Scientific Officer
Signature
/s/ Sergei M. Gryaznov
Stock symbol
MAIA
Transactions as of
Apr 30, 2024
Transactions value $
$0
Form type
4
Date filed
4/30/2024, 05:05 PM
Previous filing
Jan 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +141K $0.00 141K Apr 26, 2024 Common Stock 141K $2.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on April 26, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversay of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.